Publication | Open Access

An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma

MedicineOperable HeadImmunologyImmune Checkpoint InhibitorHead And Neck CancerAntibody EngineeringCancer TreatmentNeck OncologyImmunotherapyOncologyRadiation OncologyCancer Research